Co-Diagnostics (NasdaqCM:CODX) Q4 2025 Earnings call March 31, 2026 04:30 PM ET Company ParticipantsAndrew Benson - Head of Investor RelationsBrian Brown - CFODwight Egan - CEOConference Call ParticipantsMichael Okunewitch - Senior Analyst of BiotechnologyNone - AnalystOperatorToday's session is being recorded. It is now my pleasure to turn the floor over to Head of Investor Relations, Mr. Andrew Benson. Please go ahead, sir.Andrew BensonGood afternoon, everyone. Thank you all for participating in today's c ...